As the world’s largest and most broadly based healthcare company, Johnson & Johnson has a unique ability to apply its expertise and partnering power to solve some of the most difficult global health challenges.
The values that guide decision-making at Johnson & Johnson are spelled out in “Our Credo”, originally written in 1943. Put simply, Our Credo challenges the people of Johnson & Johnson to put the needs and well-being of the people it serves first. This includes a commitment to support the communities in which we live and work and to the world community as well.
We make a strategic and positive impact for all of our stakeholders through our long-term approach to sustainable procurement including economic, social and environmental sustainability. This means that we work closely with our global supplier community to amplify and expand the reach of our activities beyond today—for our collective future.”
In 2021, Johnson & Johnson built on prior years to launch a new, comprehensive set of goals. The Health for Humanity 2025 Goals represent an ambitious next step in the Company’s purpose to blend heart, science, and ingenuity to profoundly change the trajectory of health for humanity.
The set of 21 Goals focus on citizenship and sustainability, reflecting a commitment to advance a healthier world where people and communities can thrive, so the next generation is healthier than the last. One of the goals is a commitment to achieve $4.5 Billion of Global Impact spend around the world, which includes advancing spend with Social Enterprises in the UK.
As one of seven founding partners of the Buy Social Corporate Challenge, the flagship program of Social Enterprise UK that seeks to promote the use of social enterprises in corporate supply chains, the Johnson & Johnson Family of Companies in the UK continued taking a lead role in advancing this programme.
